Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-05-30 4:10 pm Purchase | 2024-05-22 | 13G | Edible Garden AG Incorporated EDBL | Mitchell P. Kopin | 6,379 4.990% | 6,379![]() (New Position) | Filing History |
2024-05-29 4:54 pm Purchase | 2024-05-20 | 13G | Interactive Strength Inc. TRNR | Mitchell P. Kopin | 34 5.300% | 34![]() (New Position) | Filing History |
2024-05-23 4:06 pm Purchase | 2024-05-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX | Mitchell P. Kopin | 4,429 4.990% | 4,429![]() (New Position) | Filing History |
2024-05-15 4:47 pm Purchase | 2024-05-09 | 13G | Tivic Health Systems, Inc. TIVC | Mitchell P. Kopin | 19,104 4.990% | 19,104![]() (New Position) | Filing History |
2024-05-14 4:15 pm Purchase | 2024-05-09 | 13G | Helius Medical Technologies, Inc. HSDT | Mitchell P. Kopin | 120 4.990% | 120![]() (+15203.05%) | Filing History |
2024-05-09 5:22 pm Purchase | 2024-04-28 | 13G | Innovative Eyewear, Inc. LUCY | Mitchell P. Kopin | 51,880 5.900% | 23,410![]() (+82.22%) | Filing History |
2024-05-08 5:16 pm Purchase | 2024-05-01 | 13G | Tantech Holdings Ltd TANH | Mitchell P. Kopin | 20,379 9.990% | 20,379![]() (New Position) | Filing History |
2024-05-08 5:13 pm Purchase | 2024-04-29 | 13G | TFF Pharmaceuticals, Inc. TFFP | Mitchell P. Kopin | 155,589 4.990% | 155,589![]() (New Position) | Filing History |
2024-05-03 4:13 pm Purchase | 2024-04-26 | 13G | Nuwellis, Inc. NUWE | Mitchell P. Kopin | 23,286 4.990% | 23,286![]() (New Position) | Filing History |
2024-04-24 4:32 pm Purchase | 2024-04-15 | 13G | PainReform Ltd. PRFX | Mitchell P. Kopin | 8,400 7.900% | 8,400![]() (New Position) | Filing |
2024-04-17 4:03 pm Purchase | 2024-04-08 | 13G | Longeveron Inc. LGVN | Mitchell P. Kopin | 174,054 4.990% | 174,054![]() (New Position) | Filing History |
2024-04-03 5:44 pm Purchase | 2024-03-25 | 13G | Bio-Path Holdings, Inc. BPTH | Mitchell P. Kopin | 53,700 7.100% | 53,700![]() (New Position) | Filing History |
2024-03-21 4:42 pm Purchase | 2024-03-12 | 13G | ASLAN Pharmaceuticals Limited ASLN | Mitchell P. Kopin | 3,125,000 4.400% | 3,125,000![]() (New Position) | Filing History |
2024-03-14 5:10 pm Purchase | 2024-03-04 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 16,601 9.990% | 16,601![]() (New Position) | Filing History |
2024-03-06 4:09 pm Purchase | 2024-02-26 | 13G | Aclarion, Inc. ACON | Mitchell P. Kopin | 38 4.990% | 38![]() (New Position) | Filing History |
2024-03-01 4:28 pm Purchase | 2024-02-22 | 13G | Venus Concept Inc. VERO | Mitchell P. Kopin | 29,160 4.990% | 29,160![]() (New Position) | Filing History |
2024-02-12 06:16 am Purchase | 2024-02-02 | 13G | Nuvve Holding Corp. NVVE | Mitchell P. Kopin | 41,100 8.900% | 41,100![]() (New Position) | Filing History |
2024-02-06 11:12 am Purchase | 2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ | Mitchell P. Kopin | 814,383 1.800% | 787,291![]() (+2905.99%) | Filing History |
2024-02-06 10:30 am Purchase | 2023-12-31 | 13G | OceanPal Inc. OP | Mitchell P. Kopin | 105,655 1.400% | 105,655![]() (New Position) | Filing History |
2024-02-06 10:30 am Purchase | 2023-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 99,045 9.990% | 99,045![]() (New Position) | Filing History |